CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fujian Cosunter Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fujian Cosunter Pharmaceutical Co Ltd
Block 16, Phase II, Innovation Park, Hai
Phone: +86 59138265194p:+86 59138265194 FUZHOU, FUJ  350108  China Ticker: 300436300436
Business Summary
Fujian Cosunter Pharmaceutical Co Ltd is a China-based company principally engaged in the production and sale of pharmaceuticals. The Company's main products include Tenofovir alafenamide Fumarate Tablets, Entecavir Capsules, Lamivudine Tablets, Silybin Meglumine Tablets, Adefovir Dipivoxil Tablets, Ursodeoxycholic Acid Capsules, Tadalafil Tablets, Rivaroxaban Tablets and others. The Company's products are mainly used in the fields of anti-hepatitis B virus, liver health, men's health, cardiovascular treatment and others. The Company mainly operates its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager GuopingLi 55 3/25/2020
Chief Financial Officer JianhuiGuan 48 12/27/2017 12/27/2017
Chief Operating Officer, Director FuhuHuang 49 1/13/2025 3/25/2020
10 additional Officers and Directors records available in full report.

General Information
Number of Employees: 760 (As of 12/31/2024)
Outstanding Shares: 159,267,000 (As of 6/30/2025)
Shareholders: 16,569
Stock Exchange: SHE
Fax Number: +86 59138305305


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, September 4, 2025
Register now for our FAST Rating webinar on September 10 at 2:00 PM ET!